 | • レポートコード：B-GIR08C0323 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、抗腫瘍薬の世界市場について調べ、まとめました。種類別セグメントは、ホルモン・拮抗薬、微生物製品、植物製品、抗腫瘍抗生物質、アルキル化剤、代謝拮抗剤、天然物等、用途別セグメントは、等に区分しました。抗腫瘍薬の世界市場概観、企業動向、企業別抗腫瘍薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・抗腫瘍薬の市場概観 ・抗腫瘍薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・抗腫瘍薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・抗腫瘍薬の世界市場規模 ・抗腫瘍薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・抗腫瘍薬のアメリカ市場規模推移 ・抗腫瘍薬のカナダ市場規模推移 ・抗腫瘍薬のメキシコ市場規模推移 ・抗腫瘍薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・抗腫瘍薬のドイツ市場規模推移 ・抗腫瘍薬のイギリス市場規模推移 ・抗腫瘍薬のロシア市場規模推移 ・抗腫瘍薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・抗腫瘍薬の日本市場規模推移 ・抗腫瘍薬の中国市場規模推移 ・抗腫瘍薬の韓国市場規模推移 ・抗腫瘍薬のインド市場規模推移 ・抗腫瘍薬の東南アジア市場規模推移 ・抗腫瘍薬の南米市場分析（ブラジル、アルゼンチン等） ・抗腫瘍薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・抗腫瘍薬の種類別分析/販売量、売上、市場シェア（ホルモン・拮抗薬、微生物製品、植物製品、抗腫瘍抗生物質、アルキル化剤、代謝拮抗剤、天然物） ・抗腫瘍薬の用途別分析/市場規模（） ・抗腫瘍薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・抗腫瘍薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agents are also known as cytotoxic agents .The changing lifestyle across the globe is increasing the chances of cancer which leads to high demand for the anti-neoplastic pharmaceutical agents from pharmaceutical companies.
Scope of the Report:
The global Anti-Neoplastic Pharmaceutical Agents market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Anti-Neoplastic Pharmaceutical Agents.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Anti-Neoplastic Pharmaceutical Agents market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Anti-Neoplastic Pharmaceutical Agents market by product type and applications/end industries.
Market Segment by Companies, this report covers
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol-Myers Squibb Company
Becton, Dickinson and Company
Pfizer Inc.
Novartis AG
AstraZeneca
Gilead
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hormones and Antagonists
Microorganism Products
Plant Products
Antitumor Antibiotics
Alkylating Agents
Antimetabolites
Natural Products
Market Segment by Applications, can be divided into
Lung Cancer
Bladder Cancer
Breast Cancer
Cervical Cancer
Leukemia
Gynecological Cancer
Other
Table of Contents
1 Anti-Neoplastic Pharmaceutical Agents Market Overview
1.1 Product Overview and Scope of Anti-Neoplastic Pharmaceutical Agents
1.2 Classification of Anti-Neoplastic Pharmaceutical Agents by Types
1.2.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue Comparison by Types (2019-2024)
1.2.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Types in 2018
1.2.3 Hormones and Antagonists
1.2.4 Microorganism Products
1.2.5 Plant Products
1.2.6 Antitumor Antibiotics
1.2.7 Alkylating Agents
1.2.8 Antimetabolites
1.2.9 Natural Products
1.3 Global Anti-Neoplastic Pharmaceutical Agents Market by Application
1.3.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Lung Cancer
1.3.3 Bladder Cancer
1.3.4 Breast Cancer
1.3.5 Cervical Cancer
1.3.6 Leukemia
1.3.7 Gynecological Cancer
1.3.8 Other
1.4 Global Anti-Neoplastic Pharmaceutical Agents Market by Regions
1.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Anti-Neoplastic Pharmaceutical Agents Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Anti-Neoplastic Pharmaceutical Agents Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-Neoplastic Pharmaceutical Agents Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Anti-Neoplastic Pharmaceutical Agents Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-Neoplastic Pharmaceutical Agents Status and Prospect (2014-2024)
1.5 Global Market Size of Anti-Neoplastic Pharmaceutical Agents (2014-2024)
2 Manufacturers Profiles
2.1 GlaxoSmithKline plc.
2.1.1 Business Overview
2.1.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
2.2 F. Hoffmann-La Roche Ltd
2.2.1 Business Overview
2.2.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
2.3 Eli Lilly and Company
2.3.1 Business Overview
2.3.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bristol-Myers Squibb Company
2.4.1 Business Overview
2.4.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
2.5 Becton, Dickinson and Company
2.5.1 Business Overview
2.5.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer Inc.
2.6.1 Business Overview
2.6.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novartis AG
2.7.1 Business Overview
2.7.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
2.8 AstraZeneca
2.8.1 Business Overview
2.8.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
2.9 Gilead
2.9.1 Business Overview
2.9.2 Anti-Neoplastic Pharmaceutical Agents Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anti-Neoplastic Pharmaceutical Agents Market Competition, by Players
3.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Anti-Neoplastic Pharmaceutical Agents Players Market Share
3.2.2 Top 10 Anti-Neoplastic Pharmaceutical Agents Players Market Share
3.3 Market Competition Trend
4 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions
4.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue and Market Share by Regions
4.2 North America Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
4.3 Europe Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
4.5 South America Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
5 North America Anti-Neoplastic Pharmaceutical Agents Revenue by Countries
5.1 North America Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
5.2 USA Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
5.3 Canada Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
5.4 Mexico Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
6 Europe Anti-Neoplastic Pharmaceutical Agents Revenue by Countries
6.1 Europe Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
6.2 Germany Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
6.3 UK Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
6.4 France Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
6.5 Russia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
6.6 Italy Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue by Countries
7.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
7.2 China Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
7.3 Japan Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
7.4 Korea Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
7.5 India Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
8 South America Anti-Neoplastic Pharmaceutical Agents Revenue by Countries
8.1 South America Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
8.2 Brazil Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
8.3 Argentina Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
8.4 Colombia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Anti-Neoplastic Pharmaceutical Agents by Countries
9.1 Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
9.2 Saudi Arabia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
9.3 UAE Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
9.4 Egypt Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
9.5 Nigeria Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
9.6 South Africa Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
10 Global Anti-Neoplastic Pharmaceutical Agents Market Segment by Type
10.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue and Market Share by Type (2014-2019)
10.2 Global Anti-Neoplastic Pharmaceutical Agents Market Forecast by Type (2019-2024)
10.3 Hormones and Antagonists Revenue Growth Rate (2014-2024)
10.4 Microorganism Products Revenue Growth Rate (2014-2024)
10.5 Plant Products Revenue Growth Rate (2014-2024)
10.6 Antitumor Antibiotics Revenue Growth Rate (2014-2024)
10.7 Alkylating Agents Revenue Growth Rate (2014-2024)
10.8 Antimetabolites Revenue Growth Rate (2014-2024)
10.9 Natural Products Revenue Growth Rate (2014-2024)
11 Global Anti-Neoplastic Pharmaceutical Agents Market Segment by Application
11.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Application (2014-2019)
11.2 Anti-Neoplastic Pharmaceutical Agents Market Forecast by Application (2019-2024)
11.3 Lung Cancer Revenue Growth (2014-2019)
11.4 Bladder Cancer Revenue Growth (2014-2019)
11.5 Breast Cancer Revenue Growth (2014-2019)
11.6 Cervical Cancer Revenue Growth (2014-2019)
11.7 Leukemia Revenue Growth (2014-2019)
11.8 Gynecological Cancer Revenue Growth (2014-2019)
11.9 Other Revenue Growth (2014-2019)
12 Global Anti-Neoplastic Pharmaceutical Agents Market Size Forecast (2019-2024)
12.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Forecast (2019-2024)
12.2 Global Anti-Neoplastic Pharmaceutical Agents Market Forecast by Regions (2019-2024)
12.3 North America Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
12.4 Europe Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
12.6 South America Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Anti-Neoplastic Pharmaceutical Agents Picture
Table Product Specifications of Anti-Neoplastic Pharmaceutical Agents
Table Global Anti-Neoplastic Pharmaceutical Agents and Revenue (Million USD) Market Split by Product Type
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Types in 2018
Figure Hormones and Antagonists Picture
Figure Microorganism Products Picture
Figure Plant Products Picture
Figure Antitumor Antibiotics Picture
Figure Alkylating Agents Picture
Figure Antimetabolites Picture
Figure Natural Products Picture
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) by Application (2014-2024)
Figure Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Applications in 2018
Figure Lung Cancer Picture
Figure Bladder Cancer Picture
Figure Breast Cancer Picture
Figure Cervical Cancer Picture
Figure Leukemia Picture
Figure Gynecological Cancer Picture
Figure Other Picture
Table Global Market Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) and Growth Rate (2014-2024)
Table GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Type and Applications
Table GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Type and Applications
Table F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Type and Applications
Table Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Type and Applications
Table Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Type and Applications
Table Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Type and Applications
Table Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Anti-Neoplastic Pharmaceutical Agents Type and Applications
Table Novartis AG Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Anti-Neoplastic Pharmaceutical Agents Type and Applications
Table AstraZeneca Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Basic Information, Manufacturing Base and Competitors
Table Gilead Anti-Neoplastic Pharmaceutical Agents Type and Applications
Table Gilead Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) by Players (2014-2019)
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Players (2014-2019)
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Players in 2017
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Players in 2018
Figure Global Top 5 Players Anti-Neoplastic Pharmaceutical Agents Revenue Market Share in 2018
Figure Global Top 10 Players Anti-Neoplastic Pharmaceutical Agents Revenue Market Share in 2018
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) by Regions (2014-2019)
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Regions (2014-2019)
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Regions (2014-2019)
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Regions in 2018
Figure North America Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Europe Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure South America Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Table North America Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
Table North America Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries (2014-2019)
Figure North America Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries (2014-2019)
Figure North America Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries in 2018
Figure USA Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Canada Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Mexico Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Table Europe Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) by Countries (2014-2019)
Figure Europe Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries (2014-2019)
Figure Europe Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries in 2018
Figure Germany Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure UK Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure France Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Russia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Italy Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries in 2018
Figure China Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Japan Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Korea Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure India Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Table South America Anti-Neoplastic Pharmaceutical Agents Revenue by Countries (2014-2019)
Table South America Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries (2014-2019)
Figure South America Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries (2014-2019)
Figure South America Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries in 2018
Figure Brazil Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Argentina Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Colombia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Countries in 2018
Figure Saudi Arabia Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure UAE Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Egypt Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure Nigeria Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Figure South Africa Anti-Neoplastic Pharmaceutical Agents Revenue and Growth Rate (2014-2019)
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) by Type (2014-2019)
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Type (2014-2019)
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Type (2014-2019)
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Type in 2018
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue Forecast by Type (2019-2024)
Figure Global Anti-Neoplastic Pharmaceutical Agents Market Share Forecast by Type (2019-2024)
Figure Global Hormones and Antagonists Revenue Growth Rate (2014-2019)
Figure Global Microorganism Products Revenue Growth Rate (2014-2019)
Figure Global Plant Products Revenue Growth Rate (2014-2019)
Figure Global Antitumor Antibiotics Revenue Growth Rate (2014-2019)
Figure Global Alkylating Agents Revenue Growth Rate (2014-2019)
Figure Global Antimetabolites Revenue Growth Rate (2014-2019)
Figure Global Natural Products Revenue Growth Rate (2014-2019)
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue by Application (2014-2019)
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Application (2014-2019)
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Application (2014-2019)
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue Share by Application in 2018
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue Forecast by Application (2019-2024)
Figure Global Anti-Neoplastic Pharmaceutical Agents Market Share Forecast by Application (2019-2024)
Figure Global Lung Cancer Revenue Growth Rate (2014-2019)
Figure Global Bladder Cancer Revenue Growth Rate (2014-2019)
Figure Global Breast Cancer Revenue Growth Rate (2014-2019)
Figure Global Cervical Cancer Revenue Growth Rate (2014-2019)
Figure Global Leukemia Revenue Growth Rate (2014-2019)
Figure Global Gynecological Cancer Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Anti-Neoplastic Pharmaceutical Agents Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
Figure Europe Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
Figure South America Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Anti-Neoplastic Pharmaceutical Agents Revenue Market Forecast (2019-2024)
抗移動剤市場：世界及び中国市場分析・予測（～2024年） Anti Migrating Agents Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Anti Migrating Agents industry with a focus on the Chinese market. The report provides key statistics on the market status of the Anti Migrating Agents manu…- 抗幼若ホルモン剤市場：世界及び中国市場分析・予測（～2024年） Anti-juvenile Hormone Agents Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Anti-juvenile Hormone Agents industry with a focus on the Chinese market. The report provides key statistics on the market status of the Anti-juvenil…
- 抗アレルギー薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Anti-Allergic Agents is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Anti-Allergic Agents in glob…
- 前処理濾過剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Pretreatment filming agent is a kind of chemical agent which can form protective film on metal surface in the pretreatment of water treatment. Scope of the Report: The worldwide market for Pretreatment Filming Agents is expected to grow at a CAGR of roughly xx% over the next five years, will reach x…
- 交感神経興奮薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Sympathomimetic Agents market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, al…